 |
인쇄하기
취소
|
Lilly Korea launches ActosMet
Lilly Korea says it has launched its ActosMet (Actos 15 mg + metformin 850 mg) tablets for treatment of 2 diabetes - namely insulin resistance.
Actos is a clinically proven, once a day medicine that belongs to a class of oral Type 2 diabetes drugs called thiazoildinediones. Additionally, Actos is also indicated for oral combination treatment in type 2 diabetes at doses up to 45 mg in patient...
Actos is a clinically proven, once a day medicine that belongs to a class of oral Type 2 diabetes drugs called thiazoildinediones. Additionally, Actos is also indicated for oral combination treatment in type 2 diabetes at doses up to 45 mg in patient...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.